Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,455,071
-
Share change
-
-917,178
-
Total reported value
-
$2,508,000
-
Price per share
-
$0.46
-
Number of holders
-
21
-
Value change
-
-$1,134,057
-
Number of buys
-
4
-
Number of sells
-
17
Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q2 2017
As of 30 Jun 2017,
REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,455,071 shares.
The largest 10 holders included
FMR LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., GENERAL AMERICAN INVESTORS CO INC, Allegis Investment Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Hudson Bay Capital Management LP, and NORTHERN TRUST CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.